Abstract:Introduction An estimated 2.8 million people worldwide are currently diagnosed with Multiple Sclerosis (MS). Moreover, cis-gender females are almost twice as likely to have the diagnosis than cis-gender males. Among the many physical symptoms secondary to MS, the ones related to the sex organs include numbness, vaginal dryness, erectile dysfunction and loss of libido, low desire, issues with lubrication, lack of sensation, difficulties with arousal, difficulties reaching orgasm and sexual pain. These symptoms are typically underreported, under diagnosed, and patients may find it difficult to address with a clinician. In addition, generalized fatigue, spasticity, muscle weakness, psychological changes, bowel and bladder dysfunction that also occur with MS can place strain on sexual relations with a partner and overall quality of life. Data suggest that 59.8% of cis gender females with MS report sexual dysfunction but only about 22.4% brought it up with a physician. Moreover, this study also found that 80% of these individuals wanted treatment for their sexual symptoms, highlighting the importance of exploring interventions for sexual dysfunction in MS patients. Objective This review investigated the options available for sexual dysfunction in cis gender females with MS. Methods Online databases such as Rutgers Library, PubMed, ScienceDirect, Cochrane Library and Google Scholar with key phrases such as "MS and endocrine symptoms" and "MS and sexual changes", were used. Results Data suggest that several non-pharmacological interventions may be effective in decreasing the severity of symptoms related to sexual dysfunction in individuals with MS. One study investigated the effectiveness of sex therapy and found that sex therapy improved quality of life for those reporting sexual dysfunction. Another study examined the effects of physical therapy on sexual symptoms and found that practices such as pelvic floor exercises also contributed to a decrease in symptom severity. Other data, reported that mindfulness psych-education group intervention also was instrumental in improving female sexual function. Further, the use of clitoral stimulation devices also were found to be highly recommended to improve sexual effects. Finally, several pharmacologic agents have been explored such as flibanserin and sildenafil, but their effectiveness was limited in regard to sexual function. Conclusions Sexual dysfunction is a major concern for individuals with MS. In this population, there is often a sense of embarrassment or feeling ashamed. Therefore, clinicians should create an open environment for patients to bring up this topic of sexuality in order to develop a comprehensive treatment plan. Additionally, more research is needed on effective treatment options, both short and long term for MS patients dealing with sexual dysfunction. Disclosure No.

Switching from injectable to other Disease Modifying Therapies may improve sexual dysfunction in people with Multiple Sclerosis

(041) Sexual Dysfunction: A Common Problem In Individuals With Multiple Sclerosis

Systematic review of the prevalence, symptomatology and management options of sexual dysfunction in women with multiple sclerosis

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study

Evaluating Sexual Health in Women with Multiple Sclerosis: A Study on the Interplay of Disability and Quality of Life

Sex impacts treatment decisions in multiple sclerosis

Supervised Pelvic Floor Muscle Training Improves Sexual Function and Diminishes Sexual Distress in Women with Relapsing-Remitting Multiple Sclerosis: A Randomised Controlled Study

Male sexual and reproductive health in multiple sclerosis: a scoping review

AB085. Systematic Review and Meta-Analysis of Phosphodiesterase Type 5 Inhibitors for the Treatment of Female Sexual Dysfunction

Multiple Sclerosis and Serotonin: Potential Therapeutic Applications

Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events

OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results

Adverse Drug Reactions of Multiple Sclerosis Disease-modifying Drugs

Investigation of sexual dysfunction and depression prevalence in neuromyelitis optica spectrum disorder

Percutaneous Tibial Nerve Stimulation's Impact on Sexual Function in Female Patients with Neurogenic Detrusor Overactivity, Sexual Dysfunction, and Multiple Sclerosis

Impact of sex on clinical outcome in early Multiple Sclerosis

Altered Steroidome in Women with Multiple Sclerosis

Erectile dysfunction in patients with multiple sclerosis

Expectations about the management of sexual dysfunction in women with multiple sclerosis and association with clinical characteristics

Female sexual dysfunction in psoriasis: a systematic review and meta-analysis using the Female Sexual Function Index